Anti-smoking advertising sponsored by tobacco companies not only has no negative effect on teen smoking, it may actually encourage youngsters to smoke, a new study suggests. Prevention ads aimed at parents also tend to backfire.
Rice University physicist Michael Deem is taking zeolite design into the 21st Century using a combination of supercomputers at the University of Texas at Austin and disused computing cycles from more than 4,300 idling desktop PCs at Purdue University to create a database containing more than 3.4 million atomic formulations of the porous silicate minerals. Zeolites — there are 50-odd naturally occurring ones and about 180 synthetics — are heavily used by chemical manufacturers.
Commercial activity permitted in schools, such as soft drink ads; the use of Channel One broadcasts in classrooms; sales incentives from soft drink bottlers; and exclusive beverage contracts may discourage a “nutrition-friendly” environment for students, says researchers.
Mount Sinai School of Medicine and EXACT Sciences Corporation (NASDAQ: EXAS) announced today the publication of results from a prospective, multi-center study of stool DNA testing. The study found that the test demonstrated an 88% sensitivity for colorectal cancer, and with equal detection across all stages of cancer, regardless of the cancer?s location in the colon.
Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. today announced the launch of ABILIFY? (aripiprazole) Injection, an injectable form of ABILIFY, for intramuscular use. ABILIFY Injection provides rapid control of agitation in adults with schizophrenia or bipolar mania at primary endpoint (2 hours).
Today, Bristol-Myers Squibb Company (NYSE: BMY) announced results of a randomized Phase II study showing that a substantial number of patients with chronic-phase chronic myelogenous leukemia (CML) resistant to Gleevec achieved cytogenetic and hematologic responses by three months and maintained these responses through one year when treated with SPRYCEL.
Today, Bristol-Myers Squibb Company (NYSE: BMY) announced results from a randomized Phase III study showing that patients receiving SPRYCEL 100 mg once a day achieved similar cytogenetic responses at six months with considerably fewer hematologic and non-hematologic adverse events than patients receiving three other dosing schedules of SPRYCEL.
Egyptian Health Minister Dr. Hatem Mostafa El-Gabaly today opened a new $32 million tablet factory built by AstraZeneca near Cairo ? the company?s first manufacturing investment in the Middle East. David Brennan, Chief Executive Officer of AstraZeneca, also attended the opening ceremony at the factory in 6th of October City.
Eli Lilly and Company (NYSE: LLY) announced today that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration’s Division of Drug Oncology Products (DDOP) for EVISTA? (raloxifene HCl) for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer.
The U.S. Food and Drug Administration (FDA) is currently working with five states and the Centers for Disease Control and Prevention to investigate an outbreak of norovirus which has been associated with raw, frozen oysters on the half shell from South Korea.